ptsd

FDA rejects MDMA-assisted therapy for PTSD treatment

FDA rejects MDMA-assisted therapy for PTSD treatment

Drugmaker Lykos Therapeutics announced on Aug. 9, 2024, that the Food and Drug Administration declined to approve the company’s application for the use of MDMA-assisted therapy in the treatment of post-traumatic stress disorder. It is…